Kadima Neuropsychiatry Institute sues NRx Pharma over alleged breach, misrepresentation in acquisition deal

NRX Pharmaceuticals, Inc.

NRX Pharmaceuticals, Inc.

NRXP

0.00
  • Kadima Neuropsychiatry Institute sued NRx Pharmaceuticals in San Diego County Superior Court over a planned acquisition announced in 2025.
  • Complaint alleges breach of contract, misrepresentation; seeks specific performance to force closing on the signed terms.
  • Kadima claims NRx warranted it had sufficient immediately available funds in the May 9, 2025 agreement.
  • Plaintiffs allege NRx lacked committed financing, later described the deal as subject to financing in a press release and an SEC 8-K.
  • Suit also alleges shifting financing claims tied to Universal Capital, with later SEC disclosure stating financing for the acquisition was not finalized.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NRX Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202606241318BIZWIRE_USPR_____20260624_BW388810) on June 24, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.